FindTrial
Sign In

Study of samprapti of COVID-19 & its association with ABO blood group

Study of samprapti of COVID-19 & its association with ABO blood group - A cross sectional study.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/05/042873
Enrollment
125
Registered
2022-05-27
Start date
Unknown
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Ch Brahm Prakash Ayurved Charak Sansthan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Already diagnosed patients of COVID-19. Patient of either sex of any age. Patient willing to participate in trial & sign consent form.

Exclusion criteria

Exclusion criteria: Patients who are not willing for trial.

Design outcomes

Primary

MeasureTime frame
Description of samprapti (pathogenesis) of COVID-19 as per Ayurveda By finding association between COVID-19 and blood group, potential risk related with any blood group can be evaluated so that the person with susceptible blood group may take more precautions than people with other blood groups.Timepoint: Single time study—

Secondary

MeasureTime frame
nilTimepoint: nil—

Countries

India

Contacts

Public ContactDr Aditaya Nath Tewari

Ch. Brahm Prakash Ayurved Charak Sansthan

dr.aditaya@gmail.com9711434847

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026